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Abstract
Next generation sequencing has dramatically increased our ability to localize disease-causing variants by providing base-
pair level information at costs increasingly feasible for the large sample sizes required to detect complex-trait associations.
Yet, identification of causal variants within an established region of association remains a challenge. Counter-intuitively,
certain factors that increase power to detect an associated region can decrease power to localize the causal variant. First,
combining GWAS with imputation or low coverage sequencing to achieve the large sample sizes required for high power
can have the unintended effect of producing differential genotyping error among SNPs. This tends to bias the relative
evidence for association toward better genotyped SNPs. Second, re-use of GWAS data for fine-mapping exploits previous
findings to ensure genome-wide significance in GWAS-associated regions. However, using GWAS findings to inform fine-
mapping analysis can bias evidence away from the causal SNP toward the tag SNP and SNPs in high LD with the tag.
Together these factors can reduce power to localize the causal SNP by more than half. Other strategies commonly
employed to increase power to detect association, namely increasing sample size and using higher density genotyping
arrays, can, in certain common scenarios, actually exacerbate these effects and further decrease power to localize causal
variants. We develop a re-ranking procedure that accounts for these adverse effects and substantially improves the accuracy
of causal SNP identification, often doubling the probability that the causal SNP is top-ranked. Application to the NCI BPC3
aggressive prostate cancer GWAS with imputation meta-analysis identified a new top SNP at 2 of 3 associated loci and
several additional possible causal SNPs at these loci that may have otherwise been overlooked. This method is simple to
implement using R scripts provided on the author’s website.
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Introduction
The challenges of precise identification of disease-causing
variants underlying GWAS signals have recently received much
attention [1–3]. For post-GWAS statistical analysis that aims to
accurately identify potentially causal variants, a major hurdle is the
development of methods to distinguish disease-causing variants
from their highly-correlated proxies. While GWAS-era statistical
methods focused on identifying associated regions via tag SNPs at
the coarse scale of GWAS arrays, next generation sequencing
(NGS) technology offers the capability to not only detect associated
regions, but to distinguish the causal SNPs within these associated
regions. Here we make a distinction between ranking SNPs across
the genome to identify an associated region, and ranking to
pinpoint the potential causal variant within an associated region.
Identifying an associated region requires that trait-associated SNPs
be ranked above null SNPs, while identifying the causal variant
requires that, among associated SNPs, associations due to causality
are ranked above indirect associations due to other factors, e.g.
linkage disequilibrium (LD). GWAS and imputation studies
typically report the top-ranked SNP for each associated locus,
and follow-up studies typically attempt replication for these top-
ranked SNPs (for further discussion of ranking see Text S1).
Zaitlen et al [4] proposed a measure of performance for
sequencing and fine mapping analysis, their localization success
rate metric is the probability that the causal SNP has the top-
ranked test statistic within an associated region. When multiple
SNPs are in high LD, the localization success rate drops
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overcoming the stochastic effect of high LD among causal and
non-causal SNPs [5]. The sample size required to distinguish the
causal SNP can be 1 to 4 times the size required to detect the
association at genome-wide significance. Zaitlen et al [4] showed
that this problem could be overcome through joint analysis of
samples from carefully selected populations with differing LD
structure. Although candidate causal SNPs will require further
bioinformatic or functional study to ultimately delineate potential
causal mechanisms, optimized study design and analysis can point
to the best possible candidate causal SNP(s) and help develop
testable hypotheses about biological mechanisms.
Studies of complex traits now underway are leveraging the cost
efficiency of integrating GWAS, low- and high-coverage sequenc-
ing, and imputation to achieve sample sizes in the tens of
thousands [6,7]. For example, the Genetics of Type 2 Diabetes
(GoT2D) study is combining low and high-coverage sequencing
with 2.5M-SNP GWAS genotyping and imputation to achieve a
total sample size of over 28,000 [8]. Sequencing the GWAS
sample exploits the GWAS findings to ensure that an association
signal is present at the genome-wide level and eliminates the cost
of recruiting new individuals. Analysis of sequenced and imputed
SNPs (post-GWAS data) can thus be informed by previous GWAS
results, allowing a prioritized use of post-GWAS data in fine-
mapping regions surrounding significant GWAS tag SNPs [9–11].
Selection of associated regions for further studies can also be based
on combined GWAS and post-GWAS criteria [12,13]. For
example, the WTCCC [13] required a marginally significant (p-
value,10
24) GWAS SNP to support the evidence at a genome-
wide significant imputed SNP. However, these strategies lead to
two important issues that have received little attention in the
context of causal SNP identification: (1) the effect of the re-use of
successful GWAS data and (2) the effect of genotyping error rates
that differ between sequenced or imputed SNPs.
The re-use of GWAS data that had contributed to the
identification of an associated region for post-GWAS analysis
can adversely affect accurate causal SNP identification. For
example, the simulation study of Wiltshire et al [14] showed that
when a significant GWAS tag SNP is followed up by sequencing in
the same sample, the tag SNP is in fact ranked higher than the true
causal SNP 30% to 63% of the time, depending on the genetic
model and effect size. When a GWAS tag SNP is selected based on
small p-value, the magnitude of the association at the tag tends to
be over-estimated; this form of selection bias is also known as the
winner’s curse [15–19]. To a variable extent, depending on the
LD pattern, this selection bias is carried over from the GWAS tag
to post-GWAS sequenced or imputed SNPs [20]. While this earlier
work empirically demonstrated the effect of selection for a
significant GWAS tag SNP on the causal SNP, no work to date
explores whether it also affects the rank of the causal SNP among
all neighboring SNPs within an associated region, and if so how to
correct for the bias.
High error rates and differences in error rates, due to differences
in coverage, read length and depth, minor allele frequency (MAF),
GC content, local sequence structure, and other sequence-specific
factors, are common to NGS SNPs and are well-recognized
obstacles to analysis [21–29]. Error rates for low-read-depth
sequencing studies are estimated to be 1%–3% [22,30,31], and as
little as 1% error can produce a large loss in power [27]. The
strategy of low-coverage sequencing in a portion of GWAS samples
has been used to discover sequencing variants and build a reference
panel to drive imputation in the remaining samples, but the
genotyping accuracy can be worse than if all individuals were
sequenced [25]. The choice of lower-coverage design is also
motivated by reports that low-coverage sequencing in a large
sample, alone or combined with GWAS and imputation data, can
achieve superior power to detect associations compared to high-
coverage sequencing in a small sample with similar cost
[25,29,32,33]. However, whether the localization success rate of
the causal variants responsible for these associations is similarly high
has not yet been examined.High error rates that differ among SNPs
also occur in high-coverage sequencing; for example, within
targeted high-coverage regions, highly repetitive elements can be
difficult to capture resulting in low accuracy for some SNPs [34].
Differential genotyping accuracy between studies has been
shown to reduce power of meta-analysis in the imputation setting
[35], and differential accuracy between cases and controls has
been shown to cause confounding and elevated type I error
[36,37]. Accounting for differential genotyping accuracy in the
association test can recover some of the lost power and reduce type
I error [35,36]. However, whether it affects our ability to
distinguish causal SNPs from correlated SNPs, and how best to
account for the effect of differential genotyping accuracy jointly for
all SNPs (GWAS tagged, imputed or sequenced) is an open
question.
In this report, we first demonstrate that:
(1) Localization success rate decreases as the correlation between
the tag and causal SNP increases.
(2) Selection at the tag SNP exacerbates this problem by
increasing the magnitude of the association evidence at the
tag SNP itself and at other neighboring SNPs in higher LD
with the tag relative to the causal SNP.
(3) Differential genotyping or imputation error between SNPs
further decreases localization success rate, with or without the
tag selection.
(4) This problem can be exacerbated by increasing sample size, if
genotyping accuracy at the causal SNP is lower than at
neighboring SNPs.
We develop an analytic description of how these factors
influence the probability of localization success and evaluate this
Author Summary
As next-generation sequencing (NGS) costs continue to fall
and genome-wide association study (GWAS) platform
coverage improves, the human genetics community is
positioned to identify potentially causal variants. However,
current NGS or imputation-based studies of either the
whole genome or regions previously identified by GWAS
have not yet been very successful in identifying causal
variants. A major hurdle is the development of methods to
distinguish disease-causing variants from their highly-
correlated proxies within an associated region. We show
that various common factors, such as differential sequenc-
ing or imputation accuracy rates and linkage disequilibri-
um patterns, with or without GWAS-informed region
selection, can substantially decrease the probability of
identifying the correct causal SNP, often by more than half.
We then describe a novel and easy-to-implement re-
ranking procedure that can double the probability that the
causal SNP is top-ranked in many settings. Application to
the NCI Breast and Prostate Cancer (BPC3) Cohort
Consortium aggressive prostate cancer data identified
new top SNPs within two associated loci previously
established via GWAS, as well as several additional possible
causal SNPs that had been previously overlooked.
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show how to properly adjust for the adverse effects of these factors
with a re-ranking procedure. We evaluate the performance of the
method with extensive simulation studies under a wide range of
realistic scenarios, and we demonstrate the practical use of re-
ranking with an application to the NCBI BPC3 aggressive prostate
cancer GWAS with imputation [38].
Materials and Methods
Suppose that M sequenced (or imputed) SNPs, Si,i=1 ,… ,M ,
in the region surrounding a significant GWAS tag SNP G are ranked
by the magnitude of their association statistics in order to identify the
causal SNP C. Table 1 provides the notation for the various
parameters and statistics used throughout the report. Briefly, TSi is the
Wald test statistic at a sequenced SNP Si; ^ r rGSi i st h es a m p l eP e a r s o n
correlation coefficient between the GWAS/imputed/sequenced
genotypes (most likely or fractional allele dosage) for SNPs G and Si
(r
2 is the well-known pair-wise correlation measure of LD between
two SNPs); ^ r rSi is the estimated correlation between the true genotype
and the called genotype for a sequenced SNP Si (we use correlation as
a measure of genotyping accuracybecause of its simpleinterpretation
in terms of power and genotyping quality; this quantity is provided by
both MACH [24] and BEAGLE [39] software); dG and dSi are
proportions of samples with non-missing genotypes (termed call rates)
at SNPs G and Si, respectively, and dGSi is the joint call rate, the
proportion of samples with non-missing genotypes at both SNPs, and
dC is the call rate at the causal SNP.
Let ^ D DG be an estimate of the selection bias in genetic effect
estimation at the tag SNP G (described further below), that is the
excess in the expected value of the test statistic TG at the tag SNP
G induced by selection based on its small p-value (or high rank).
We call this phenomenon the selection effect (DG is zero if the region
was not selected via a tag SNP that achieved the given significance
or ranking criterion in the same sample). Our proposed re-ranking
statistic for a sequenced SNP Si is
T 
Si~
TSi{
dGSi ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dGdSi
p ^ r rGSi
^ D DG
ﬃﬃﬃﬃﬃﬃ
dSi
p
^ r rSi
for i~1,..., M: ð1Þ
Equation (1) depends on the selection effect ^ D DG, the tagging effect
^ r rGSi
^ D DG, the genotyping accuracy effect ^ r rSi and scaling factors that
depend on the call rates d.. Justification for Equation (1) now
follows in the remainder of this section. (Full details are provided
in Text S2.)
Without loss of generality, let b.0 be the genetic effect (e.g. the
log odds ratio or the regression coefficient in the model relating the
phenotype and genotype) at the causal SNP C which could be: one
of the sequenced or imputed SNPs Si, i =1,…, M; the GWAS tag
SNP G although this is unlikely; or neither if the genomic coverage
was incomplete. Let the tag SNP G be coded such that the coded
allele is positively correlated with the causal allele. Let ^ b b be the
genetic effect estimate and ^ s s ^ b b
  
be the estimated standard
deviation (SD) of the estimate from n observations. We assume that
Table 1. Notation.
Sequenced or imputed SNPs indexed i[ 1…M S1 , … ,.SM
Causal SNP C
GWAS tag SNP G
Test statistic at sequenced SNP i, causal SNP, GWAS tag SNP TSi, TC, TG
Observed value of the test statistic at the tag SNP TGobs
Re-ranking statistic at sequenced SNP i T 
Si
Correlation between:
Actual genotypes of casual and tag, causal and sequenced SNP i,, tag and sequenced SNP ir CG,r CSi,r GSi
Estimated genotypes for the tag and sequenced SNP i ^ r rGSi
Actual genotype of the causal SNP and estimated genotype at sequenced SNP i r 
CSi
Call rate (1-missing data rate) at sequenced SNP i, tag SNP dSi,dG
Joint call rate for tag SNP and sequenced SNP i dGSi
Correlation between actual and estimated genotypes at: sequenced SNP i, causal SNP, GWAS tag SNP rSi ,rC, rG
Estimated correlation (sample correlation) of the above ^ r rSi,^ r rC,^ r rG
Tag selection bias (E[TG| threshold selection and ranking]-E[TG]), Bootstrap estimate of the bias DG,^ D DG
Genetic effect at the causal SNP, estimate b,^ b b
Standard deviation of the estimate at the causal SNP, estimate s ^ b b
  
,^ s s ^ b b
  
Sample size n
Expected value of the test statistic at the causal SNP re-scaled for sample size mC
mC~
ET C ½ 
s ^ b b
   ﬃﬃﬃ
n
p ~
b
s ^ b b
   ﬃﬃﬃ
n
p
Standard normal critical value at significance level a Za~W 1{a=2 ðÞ Za
Standard normal cumulative distribution and density functions W, w
doi:10.1371/journal.pgen.1003609.t001
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TC~
^ b b
^ s s ^ b b
  is approximately normal, TC*N
ﬃﬃﬃ
n
p
mC,1 ðÞ , where
mC~
b
sb
_   
1
ﬃﬃﬃ
n
p . The following also applies to test statistics that are
asymptotically equivalent to the Wald test statistic.
Let DG be the difference between the observed test statistic and
its expected value,
DG~TGobs{
ﬃﬃﬃ
n
p
rCGmC: ð2Þ
Here rCG is the correlation between the genotypes of the causal C
and the tag SNP G. (We assume that the tag is coded so that it is
positively correlated with the risk allele of the causal SNP.) The
value of rCG is unobserved and needed only in the theoretical
formation of the problem not in the practical implementation,
which we discuss later. The selection effect is most pronounced
when there is low power at the tag SNP. (For discussion of this
point see Text S3).
The conditional distribution of the test statistic TSi at the
sequenced SNP Si, conditional on the value of the observed test
statistic TGobs at the tag SNP G,i s
TSi
    TG~TGobs
   no
*N
ﬃﬃﬃ
n
p
rCSimCzrGSiDG,1{r2
GSi
  
: ð3Þ
Derivation of this distribution is detailed in Text S2. The first
term,
ﬃﬃﬃ
n
p
rCSimC, is the unconditional expected association signal
at the sequencing SNP; the second term, rGSiDG, is the distortion
due to the tag SNP selection propagated through correlation.
Therefore, DG, the selection effect at the GWAS tag SNP G carries
through to each sequenced SNP Si in proportion to the correlation
rGSi between G and Si. The combination of attenuation due to LD
and upward selection bias at the tag, rGSi DG, distorts the
association evidence so that SNPs in high LD with the tag are
more likely to be top-ranked. We call this phenomenon the tagging
effect, and use an estimate to remove bias from the conditional
expected value of TSi in (3).
Third, differential call rates among SNPs (dG, dSi and dGSi) and
estimated genotyping accuracy (^ r rSi is the estimated and rSi is the
actual correlation between the called genotype and true genotype)
of sequenced or imputed SNP Si appear in both the numerator
and denominator of Equation (1). In the numerator, the tagging
bias, ^ r rGSiDG, is scaled by a factor of
dGSi ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dSidG
p because correlation
between the test statistics depends on the individual and joint call
rates at the two SNPs (see Text S2 for derivation). The bias-
corrected statistic in the numerator is scaled by 1
  ﬃﬃﬃﬃﬃﬃ
dSi
p
^ r rSi
  
because
TSi*N
ﬃﬃﬃ
n
p ﬃﬃﬃﬃﬃﬃ
dSi
q
r 
CSimC,1
  
ð4Þ
where r 
CSi is the correlation between the genotype of the causal
SNP and the called or estimated genotype of the sequenced SNP (in
contrast to rCSi, for the true genotype of the sequenced SNP).
Assuming the probability of genotyping error is independent of the
actual genotype, then r 
CSi&^ r rSirCSi. It is clear that, without
correction, smaller rSi (higher genotyping error) and smaller dSi
(higher missing data rate) tend to lower the probability that SNP Si
would be top-ranked. We call this phenomenon the genotyping
accuracy effect.
Results
Analytical study of the adverse effects of selection,
tagging and genotyping accuracy on the localization
success rate
To conceptually demonstrate the joint effects of selection,
tagging and genotyping accuracy on the localization success rate
(the probability that the causal SNP is topped ranked within an
associated region), we first consider the simplified case of 2 SNPs,
one causal (from sequencing or imputation) and one tag (from
GWAS) with correlation between the two SNPs ranging from
r=0.2 to 1 (from almost no LD to perfect LD). The inclusion of
low LD value is motivated by the fact that correlation between the
causal SNP and the best tag is often lower than expected. The
coverage of GWAS platforms tends to be overestimated for both
sequenced and imputed SNPs (see Text S4 for further discussion of
this point). We assume that the MAFs of both SNPs are 0.12, the
causal SNP has an additive odds ratio (OR) of 1.25, and selection
at the tag SNP, if present, is based on its association test p-
value,0.05 in a sample of 1000 cases and 1000 controls.
Localization success rates (before applying the proposed re-
ranking procedure) for all figures were computed based on
Equations (2)–(3) and the equation in Text S3 and by numerically
integrating over the following bivariate normal density function,
TC
TG
     
*N
ﬃﬃﬃ
n
p
mC
ﬃﬃﬃﬃﬃﬃ
dC
p
rC
rCG
 !
,
1
ﬃﬃﬃﬃﬃﬃ
dC
p
rCrCG ﬃﬃﬃﬃﬃﬃ
dC
p
rCrCG 1
 !  !
: ð5Þ
Analytical evaluations of Equation (5) were used to generate
Figures 1–3, which give insight into the relative influence of the
tagging, selection, genotyping accuracy and sample size effects
outlined in the Introduction and explicitly defined in Materials and
Methods. We find similar patterns of influence for a rare SNP
(MAF=0.02, OR=1.5; Figures S2, S4 and S6) and a higher
frequencySNP(MAF=0.25,OR=1.25;FiguresS3,S5andS7),and
when the number of non-causal SNPs increases (Figures S8, S9, S10).
(1) Tight linkage disequilibrium between SNPs can
obscure the causal SNP (Figure 1). Figure 1 left panel shows
that as the correlation between tag and causal SNPs increases (X-
axis), the expected association evidence at the tag, E[Ttag],
approaches E[Tcausal] (Figure 1A), resulting in a lower localization
success rate (Figure 1B). As expected, increasing the number of
non-causal SNPs in strong correlation with the causal SNP
increases competition for the top rank and decreases the
localization success rate (Figures S8, S9, S10). Increasing the
number of non-causal SNPs in competition with the causal from 1
to 6 decreases the localization success rate from over 50% to less
than 35% (bottom left panels of Figures 1 and S10).
(2) Selection at the tag SNP inflates the association
evidence at the tag, increasing the probability that it out-
ranks the causal SNP (Figure 1). Figure 1 right panel shows
that tag selection reduces the difference between the expected
association evidence at the tag (E[Ttag|Ttag.crit]) and the causal
(E[Tcausal|Ttag.crit]), compared with no selection, regardless of
the LD between the two SNPs (Figure 1C vs. 1A). Consequently,
the localization success rate conditional on selection can be
reduced by 25% as compared to the unconditional localization
success rate (Figure 1D vs. Figure 1B). Results are similar for the
rare SNP and more common SNP cases (Figures S2 and S3).
Re-Ranking Variants in the Post-GWAS Era
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localization success rate, with or without tag selection
(Figure 2). Low genotyping accuracy at the causal SNP reduces
the expected value of it’s test statistic, leading to decreased
localization success rate (Figure 2). For example, if the tag SNP
was genotyped with perfect accuracy (rG=1), while the causal
SNP was not, and if the genotype error at the causal SNP resulted
in rC=0.80 (the blue dash-dotted curve), then the localization
success rate would be reduced by an additional 10%–30% as
compared to perfect genotyping accuracy (the black solid curve).
Results are similar for the rare SNP and more common SNP cases
(Figures S4 and S5).
(4) Counter-intuitively, sample size can reduce
localization success rate (Figure 3). When the causal SNP
is less accurately genotyped than one of its highly correlated
proxies (i.e. rC,rG and rCG is large), the proxy SNP may capture
the association better than the causal SNP. As a result, this proxy
SNP will out-rank the causal SNP more than 50% of the time. In
this case, the localization success rate would be less than 50%, and
would decrease further as sample size increases (Figure 3). For
example, if rC=0.95, rG=1 and rCG=0.98 (red dashed line), the
localization success rate drops from 47% to 26% as sample size
increases from 100 to 10,000. Lower rc would lead to even lower
localization success rates (results not shown). This pattern is similar
for the rare SNP and more common SNP cases (Figures S6 and
S7). We also note that, depending on the NGS experiment or the
imputation parameters (e.g. the matching between the reference
and imputation samples) for estimated genotype at the causal SNP
C, the rC may not be lower bounded by the tagging rCG, which we
discuss further in Text S4.
Practical implementation of the post-GWAS re-ranking
statistics
The above analytical results demonstrate the need to correct for the
joint effects of selection, tagging and genotyping accuracy on the
localization success rate. The practical implementation of the proposed
re-ranking statistic in Equation (1) is as follows. The estimated selection
bias ^ D DG at the tag SNP G can be obtained using BR-squared that
provides Bias-Reduced estimates via Bootstrap Resampling at the
genome-wide level [40,41]. (The original program, designed to provide
estimates for the genetic effect b, has been modified slightly to provide
estimates for the test statistic T; see software documentation on author’s
website for details.)The bootstrap estimatorcan be applied whetherthe
region of interest was selected by rank or by p-value threshold. Unlike
the threshold-based likelihood and Bayesian methods [42–46], the
Figure 1. Tagging effect decreases localization success rates with or without the selection effect. The expected values of the association
test statistics at a tag SNP (red) and the causal SNP (black), shading from 25
th–75
th percentiles (A, C), and the localization success rates (B, D) for
association studies (1000 cases and 1000 controls) of one causal SNP (MAF=0.12; OR=1.25; perfect genotyping accuracy) and one tag SNP
(MAF=0.12; in varying degree of correlation with the causal SNP, r=0.2 to 1; perfect genotyping accuracy) with no selection for significance at the
tag SNP (A, B) or selection at the tag SNP requiring the test statistic TG to be significant with p-value,0.05 (C, D).
doi:10.1371/journal.pgen.1003609.g001
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entire GWAS in order to account for the effects of LD and rank on the
bias at each SNP. The valuesofthe individual and joint call rates d. are
available from the dataset, and genotype correlation ^ r rGSi can be
estimated from the sample. Correlation between the actual and
estimated genotypes at a sequenced SNP rSi can be obtained from the
mean posterior genotype (e.g. MACH ratio of variances estimate, [24])
or from the full genotype posterior probabilities (e.g. BEAGLE allelic r
2
estimate [39]). An R script that implements Equation (1) is available.
The R script calls the BR2 software (http://www.utstat.toronto.edu/
sun/Software/BR2/), which provides the essential quantity of DG if
the original GWAS dataset was used for fine-mapping.
Simulation study design
We conducted extensive simulation studies to empirically
evaluate the performance of the re-ranking method under five
general scenarios (Table 2):
N Scenario 1: GWAS used for discovery, and sequenc-
ing/imputation used for fine-mapping around GWAS
‘‘hits’’ using the same GWAS sample. Scenario 1 is a
GWAS-focused design based on the WTCCC Type 1 Diabetes
substudy data. A significant region is identified by a significant
GWAS tag SNP (p,5610
27) and followed by fine-mapping
with post-GWAS data (sequenced or imputed SNPs) in the
region surrounding the tag SNP. The SNP with the largest test
statistic in the region is selected as the best candidate causal
SNP. Data is simulated as follows.
# GWAS Data and Tag SNP: In order to generate realistic
data, we used the individual level genotypes from the
WTCCC T1D sub-study as the GWAS data (1963 cases and
2938 controls); by fixing the genotypes we preserve realistic
LD correlation structure over the entire genome. Among the
reported WTCCC T1D significant regions, we randomly
selected 12q24 109.82–111.49 Mb as the region of interest
and designated rs11066410 (MAF 4.8%) as the GWAS tag
SNP. In Scenario 1, the GWAS data are the WTCCC T1D
substudy including GWAS genotyping data on all 4901
subjects. By fixing the genotypes we preserve realistic LD
structure over the entire genome. We then simulate
phenotype datasets that are significant at the tag SNP,
rs11066410. Other tag SNPs in the region could be also
significant, however in order to tease out the effect of tagging
from other factors such as LD structure between sequencing
SNPs in the region and MAF, we selected simulation
datasets conditional on significance at rs11066410.
# Sequencing/Imputation Data and Causal SNP: We
simulated sequencing data for the region of interest with 10
Figure 2. Low genotyping accuracy further reduces localization success rates with or without the selection effect. Localization success
rates for association studies (1000 cases and 1000 controls) of one causal SNP (MAF=0.12; OR=1.25; imperfect genotyping accuracy due to
sequencing or imputation errors resulting in correlation between the actual and estimated genotypes rC=0.80 (blue dash-dotted) to 1 (black solid)
and one tag SNP (MAF=0.12; in varying degree of correlation with the causal SNP, rCG=0.2 to 1 (X-axis); perfect genotyping accuracy with rG=1)
with no selection for significance at the tag SNP (A) or selection at the tag SNP requiring the test statistic TG to be significant with p-value,0.05 (B).
doi:10.1371/journal.pgen.1003609.g002
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OR=1.5. We varied the correlation between the tag and the
causal SNP from r=0.78 (causal not well tagged by the
GWAS SNP) to 1 (the GWAS tag SNP is the causal,
although this is an unlikely scenario). We introduced random
error into post-GWAS SNP genotypes at per-allele rates 2%,
1.5%, 1%, 0.5%, 0.25% or 0%, so that the average rSi in
each case was 0.82, 0.86, 0.90, 0.95, 0.97 or 1, respectively.
Each sequencing SNP is in LD with the causal SNP as well.
The correlation between the sequencing SNPs and the
causal SNP ranges from 0.78 to 0.975.
# Phenotype: Phenotype datasets significant (p,5610
27)a t
the GWAS tag SNP were simulated using a logistic model
with causal SNP OR=1.5.
N Scenario 2: All GWAS and sequenced/imputed SNPs
used for discovery and fine-mapping in the same
dataset. Here we assumed that all GWAS and post-GWAS
SNPs are used to identify an associated region (p,5610
27),
and the most significant SNP in the region is then identified as
the best candidate causal SNP. GWAS tag SNP data were
simulated with MAF 5%. Sequencing data were simulated as
described in Scenario 1 with parameter values detailed in
Table 2. Phenotype datasets significant (p,5610
27) at any
GWAS or post-GWAS SNP, were simulated using a logistic
model with causal SNP OR=2.
N Scenario 3: Discovery and fine-mapping using differ-
ent datasets. In this scenario, the region of interest was
discovered in a previous study, while sequencing is performed
in an independent dataset without conditioning on significance
of the GWAS tag SNP in the independent dataset. Genotype
and phenotype data were simulated as in Scenario 2, except
that phenotype datasets were not selected for significance.
N Scenario 4: Multiple causal SNPs. To explore the effect
of multiple causal SNPs, we re-considered scenario 3 but we
assumed there are 11 fine-mapping sequenced/imputed SNPs,
among which 2 are causal (both OR=2).
N Scenario 5: Missing data. This scenario focuses on the
effect of missing data (e.g. imperfect call rate). Genotype and
phenotype data were simulated as in Scenario 3, except that
genotyping accuracy was perfect. The missing rates were
randomly assigned to each SNP so that the missing data
proportion was between zero and twice the average error rate.
The parameter values in Table 2 were chosen to best reflect
realistic scenarios. For example, in order to address realistic
tagging, we examined the Affymetrix 5.0 chip and identified the
SNP that best captured each significant WTCCC T1D GWAS
SNP. The correlation between the two SNPs ranges from r=0.79
to 1. For the range of genotyping accuracy, we note that in
practice, the average sequencing r can vary substantially from
study to study. For example, for low-coverage studies, it can vary
from 0.63 to 0.99 depending on the coverage, MAF and sample
size [25]. When low-coverage sequencing (46) and imputation are
combined, the average r can range from 0.89 to 0.99 depending
on the reference panel size [24]. Sequencing r also depends on
MAF; the same error rate in a lower MAF SNP results in a smaller
r.
Even when the average r is high, SNP-level r can vary widely
within a single study. Browning and Browning [39] found that
imputation with a phased reference panel of 60 Hapmap CEU
samples yielded a median r of 0.95, however individual r was less
Figure 3. Well-tagged causal SNPs sequenced with low accuracy are unlikely to be correctly identified even as sample size
increases. Localization success rates for association studies (sample size from 50:50 cases:controls to 5000:5000 cases:controls, X-axis) of one causal
SNP (MAF=0.12; OR=1.25; imperfect genotyping accuracy due to sequencing or imputation errors resulting in correlation between the actual and
estimated genotypes rC=0.95) and one tag SNP (MAF=0.12; in high correlation with the causal SNP, rCG=0.8 (purple solid) to 0.98 (red dashed); 100%
genotyping accuracy with rG=1) with no selection for significance at the tag SNP.
doi:10.1371/journal.pgen.1003609.g003
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also vary widely between SNPs (Figure S1) by examining the 1000
Genomes low-coverage whole-genome pilot data from chromo-
some 1 in the CHB and JPT samples (Figure S1; October 2010
release; 1000 Genomes Project, 2010). We mimicked this
variability in our simulations by randomly assigning each SNP
in each dataset an error rate that ranged from zero to twice the
overall average error rate. No random error however was
introduced into the genotypes of the tag SNP (rG=1), because
GWAS genotyping has been estimated to be over 99.8% accurate
[13,47]. In order to ensure realistic correlation structure among
post-GWAS sequencing/imputation SNPs, we examined all SNPs
in the regions surrounding the WTCCC T1D significant SNPs
using the HapMap3 dataset. The average correlation between
adjacent SNPs in these regions was approximately 0.975.
Simulation study results
One of the main findings of the simulation study is that GWAS-
based region selection or moderate genotyping error can
substantially reduce the probability of correctly identifying the
causal SNP (Tables 3–4 and Tables S1, S2), consistent with that of
the analytical study. For example, results detailed in Table S1
demonstrate that the combined tagging and genotyping accuracy
effect can reduce the localization success rate by over 30%.
The simulation study also shows that the proposed re-ranking
procedure can recover much of this lost power to identify the
causal SNP, increasing the localization success rates by 1.5- to 3-
fold in many cases (Table 3). When genotyping accuracy is high,
the power lost due to tagging is small and so re-ranking tends to
have little effect.
For studies using GWAS-based selection (scenario 1), the
adverse effects of tagging and genotyping accuracy on localization
success rate are strongest when the causal SNP is well tagged
(larger r) and less accurately sequenced/imputed (smaller r)
(Tables 3, 4 and S1). High-density GWAS followed up with low-
coverage sequencing would fall into this category. Well-tagged
causal SNPs tend to suffer from lower localization success rates
because the perfectly genotyped tag often captures the association
better than the imperfectly sequenced or imputed causal SNP. Re-
ranking corrects this problem, so that the localization success rate
does not depend on how well the causal SNP is tagged, except
when the tag SNP is in fact the causal SNP. In this case, the
tagging and genotyping accuracy effects actually increase the
localization success rate. After re-ranking, the localization success
rate is similar to levels seen when the tag is not causal. We consider
this a minor tradeoff, because the causal SNP is unlikely to be
found among the GWAS SNPs for a number of reasons: GWAS
SNPs are typically selected independent of the phenotype of
interest and post-GWAS SNPs tend to greatly outnumber GWAS
SNPs.
When the discovery sample is also used for fine-mapping, but
significance is not required at the GWAS-tag SNP (scenario 2), the
Table 2. Parameters and parameter values of the main simulation studies.
Scenario 1 Scenario 2 Scenario 3 Scenario 4 Scenario 5
Effect of selection,
tagging, genotype
accuracy
Effect of selection,
genotype accuracy
Effect of
genotype
accuracy
Effect of multiple
causal SNPs
Effect of
missing
data
Sample sequenced Same as the Discovery
sample, conditional on
significance at the GWAS
tag SNP (p,5610
27)
Same as the Discovery
sample, conditional on
significance at any of
the SNPs in the region
(p,5610
27)
Independent
sample
Independent sample Independent
sample
# of GWAS tag SNPs in the region, G 11 1 1 1
# of post-GWAS SNPs (# of causal
SNPs) in the region, M
10 (1) 10 (1) 10 (1) 11 (2) 10 (1)
OR of the causal SNP(s), b 1.5 2 2 2, 2 2
MAF of the tag and post-GWAS SNPs 4.8% 5% 5% 5% 5%
Correlation between the tag
and causal SNP(s), r
0.78, 0.83, 0.85,
0.90, 0.93, 0.95, 1
0.95 0.95 0.80, 0.95 (r=0.73
between
the two causal SNPs)
0.95
Correlation between two adjacent
non-causal post-GWA SNPs, r
0.975 0.975 0.975 0.975 0.975
Correlation between the actual and called
genotypes for sequenced/imputed SNPs, rSi
0.82, 0.86, 0.90,
0.95, 0.97, 1
Same as S1 Same
as S1
Same as S1 1
Call rates (1-missing data rate), d 100% 100% 100% 100% 80%, 90%,
95%, 98%,
99% or 100%
Sample size, n 4901 (1963 cases and
2938 controls of the
WTCCC T1D study)
2500, 5000, 7500
or 10,000 (equal
cases and controls)
Same
as S2
Same as S2 Same as S2
Simulation replicates for each configuration 300 800 800 800 800
Localization Success Rate P(the causal SNP
is top-ranked)
Same as S1 Same as S1 Defined for each of
the 2 causal SNPs as
P(the causal SNP
ranks in top 2)
Same as S1
doi:10.1371/journal.pgen.1003609.t002
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power to identify the causal variant (Table 3). When an
independent sample is used for fine-mapping (scenario 3,
Table 3), localization success rates are very similar to those seen
in scenario 2. In both cases, the re-ranking method improves the
probability of correctly identifying the causal SNP. The improve-
ment is most pronounced (2- to 4-fold improvement) when
genotyping accuracy is low. When there is more than one causal
variant (scenario 4, Table 3), we find that re-ranking effectively
increases localization success rates for both causal SNPs. Imperfect
call rates affect localization success rate in a similar manner to
imperfect genotyping accuracy (scenario 5, Table 4). Equation (4)
implies that a call rate d of 0.80 should affect the distribution of the
causal SNP test statistic in the same manner as a sequencing
accuracy r of 0.89, and this is borne out in our simulations. The
re-ranking procedure corrects for both missing data and genotyp-
ing error to the same degree.
In some cases, investigators are more interested in delimiting a
set of best candidate causal SNPs instead of a single top SNP. In
the supplementary material, we include additional simulation
results for this scenario. We define an alternative localization
success rate metric as the probability that the causal SNP is in the
top 10% of SNPs by rank (Table S2). Briefly, we examine the
probability that the causal SNP is among the top 5 SNPs when
there are 50 total SNPs (ranked by test statistic or re-ranking
statistic). Without re-ranking, the probability that the causal SNP
is in the top 10% of SNPs over the region is moderate. Re-ranking
provides an improvement up to 1.8-fold.
Table 3. Localization success rates for simulation Scenarios 1, 2, 3, 4.
Average correlation between the actual and estimated genotypes of sequenced or imputed SNPs, rSi
Correlation
between the
tag and causal
SNPs, r b--------------------- Low-coverage Sequencing ---------------------c
High-coverage
Sequencing
Sample 0.82 0.86 0.90 0.95 0.97 1.00
size
b Naı ¨ve
c Re-ranked
d Naı ¨ve Re-ranked Naı ¨ve Re-ranked Naı ¨ve Re-ranked Naı ¨ve Re-ranked Naı ¨ve Re-ranked
Scenario 1
a
0.78 4901 0.20 0.38 0.21 0.42 0.23 0.42 0.34 0.60 0.29 0.49 0.42 0.60
0.83 4901 0.12 0.35 0.16 0.41 0.20 0.47 0.26 0.52 0.34 0.54 0.48 0.64
0.85 4901 0.20 0.39 0.23 0.43 0.26 0.51 0.33 0.47 0.34 0.47 0.43 0.55
0.90 4901 0.09 0.32 0.15 0.43 0.18 0.45 0.31 0.56 0.34 0.43 0.40 0.57
0.93 4901 0.08 0.41 0.12 0.35 0.19 0.40 0.34 0.53 0.44 0.54 0.45 0.56
0.95 4901 0.11 0.32 0.09 0.31 0.21 0.42 0.23 0.33 0.32 0.42 0.42 0.54
Tag is causal
e 4901 0.93 0.17 0.89 0.26 0.89 0.25 0.80 0.36 0.72 0.39 0.55 0.29
Scenario 2
a
0.95 2500 0.12 0.28 0.12 0.29 0.17 0.34 0.26 0.38 0.33 0.35 0.50 0.50
5000 0.13 0.36 0.18 0.41 0.23 0.43 0.32 0.50 0.45 0.53 0.58 0.58
7500 0.13 0.46 0.16 0.50 0.22 0.52 0.39 0.58 0.51 0.64 0.72 0.72
10000 0.12 0.48 0.16 0.53 0.23 0.55 0.37 0.67 0.54 0.68 0.74 0.74
Scenario 3
a
0.95 2500 0.12 0.24 0.14 0.28 0.18 0.29 0.28 0.35 0.33 0.36 0.46 0.46
5000 0.13 0.37 0.18 0.35 0.21 0.44 0.33 0.49 0.43 0.52 0.56 0.56
7500 0.14 0.47 0.17 0.46 0.23 0.53 0.37 0.56 0.50 0.59 0.64 0.64
10000 0.12 0.52 0.19 0.56 0.22 0.57 0.42 0.63 0.55 0.68 0.78 0.78
Scenario 4
a
0.80 2500 0.07 0.14 0.07 0.16 0.10 0.17 0.13 0.19 0.18 0.20 0.23 0.23
5000 0.05 0.14 0.07 0.16 0.08 0.17 0.13 0.17 0.16 0.20 0.21 0.21
7500 0.06 0.18 0.06 0.17 0.10 0.20 0.14 0.21 0.18 0.24 0.22 0.22
10000 0.04 0.15 0.05 0.16 0.08 0.18 0.10 0.21 0.16 0.23 0.23 0.23
0.95 2500 0.04 0.15 0.07 0.15 0.07 0.16 0.11 0.18 0.14 0.18 0.24 0.24
5000 0.04 0.13 0.04 0.14 0.05 0.18 0.10 0.17 0.13 0.18 0.20 0.20
7500 0.04 0.18 0.04 0.20 0.05 0.20 0.12 0.23 0.18 0.25 0.25 0.25
10000 0.03 0.16 0.03 0.16 0.04 0.16 0.09 0.19 0.12 0.19 0.20 0.20
aSee Table 2 for details of the simulation models; scenario 4 has two causal loci.
b1963 cases and 2938 controls for Scenario 1; equal number of cases and controls for Scenario 2,3,4.
cNaı ¨ve is standard ranking without correction for selection or genotyping error.
dRe-ranked is ranking by corrected statistic in Equation 1.
eIn this simulation, the GWAS tag SNP is causal and all post-GWAS SNPs are non-causal.
doi:10.1371/journal.pgen.1003609.t003
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Machiela et al [28] used the August 2010 release of the 1000
Genomes Project European-ancestry (EUR) panel to impute 11.6
million variants in 2,782 aggressive prostate cancer cases and
4,458 controls. These subjects were genotyped as part of the NCI
Breast and Prostate Cancer (BPC3) Cohort Consortium aggressive
prostate cancer GWAS [48,49]; genotyping platforms varied
across the seven BPC3 studies, although all used versions of the
Illumina HumanHap arrays and most used the Illumina
HumanHap 610 Quad array. The correlation between imputed
genotype dosage and genotypes thus varied across studies.
Imputation and association analyses using imputed genotype
dosages were conducted separately for each study, and the
association results were combined via fixed-effect meta-analysis.
For each imputed SNP, studies with imputation r
2,0.8 were
excluded from the meta-analysis test statistic, leaving a total of 5.8
million GWAS and imputed SNPs.
Fine-mapping in the meta-analysis context ranks SNPs by the
meta-analysis test statistic. Re-ranking requires that we compute
the correlation between the meta-analysis test statistic on the Z-
score scale (i.e. normally distributed test statistic) with and without
accounting for genotyping error. Assume Zj is the normally
distributed test statistic for study j, and wj is the weight for study j,
the meta-analysis test statistic used for the standard naı ¨ve ranking
is
Z~
P
j zjwj
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ P
j w2
j
q :
If ^ r rj is an estimate of pair-wise correlation between the actual
and imputed genotypes in study j (e.g. the square root of allelic-r
2
[39], or ratio of variances r
2 [24]), it follows that the estimated
correlation between the meta-analysis test statistic computed
with perfectly genotyped SNPs (Zact) and the meta-analysis test
statistic computed with the observed imperfectly genotyped
SNPs (Zobs)i s
^ r rmeta~cor Zobs,Zact ðÞ ~
P
j w2
j ^ r rj P
j w2
j
:
The re-ranking statistic in the meta-analysis case is
T 
Si~
TSi{^ r rGSi
dGSi ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
dGdSi
p ^ D DG
ﬃﬃﬃﬃﬃﬃ
dSi
p
^ r rmeta Si
,
whereTSi isthemeta-analysis test statisticZ scaled forvarianceof1.
Machiela et al [38] reported five statistically independent
associated regions within the 8q24.21 locus and one for each of
11q13.3 and 17q24.3. We selected all SNPs in LD (r
2.0.2) with
the index SNP from each region for analyses (Figures 4 and 5, and
Figures S11, S12, S13). In the application, we first ranked SNPs
using the naı ¨ve test statistics [38]; and excluded any SNP with
MAF ,0.01; but unlike Machiela et al [38] we did not exclude any
studies. Machiela et al selected significant regions by examining all
imputed and genotyped SNPs at once and so we corrected for the
imputation accuracy effect only (i.e. DG~0).
Re-ranking identifies new top SNPs for 2 of the 3 associated loci:
8q24.21 and 17q24.3 (Figures 4 and 5 respectively). In addition to
the most significant region at 8q24.21 (Figure 4), re-ranking also
identifies a new top SNP for the third most significant region(Figure
S11).Forboth regions re-ranking also identifiesSNPsthat mayhave
otherwise been missed due to imperfect imputation. After re-
ranking, 2 SNPs in the most significant region at the 8q24.21 locus
(Figure 4) and 8 SNPs at the 17q24.3 locus (Figure 5) move from the
lower ranks into the top 10 percent. On the other hand, SNPs in the
top 10% are moved down by only a few ranks. In this way, re-
ranking keeps highly significant SNPs identified by the naı ¨ve
ranking and adds a few SNPs that would have otherwise been
missed. When the top test statistics are of similar size, re-ranking
may identify a new top SNP. When most SNPs are well-genotyped,
re-ranking makes only subtle changes (Figure S11, S12 and S13).
There is one poorly imputed SNP at 17q24.3 (rs1014000,
r
2=0.20) that moves from the naı ¨ve rank of 245 to the new rank of
16 after adjustment. This SNP’s apparent association is largely
driven by data from a single study: the naı ¨ve rank in the EPIC
study is 10. When we remove this study from the meta-analysis,
the naı ¨ve rank is 306 and the adjusted rank is 119. No other SNP
in the top 10% is this drastically affected when the EPIC study is
removed from the analysis. In the meta-analysis context, we
recommend examining top SNPs for heterogeneity among studies
when re-ranking produces dramatically different results.
Table 4. Localization success rates for simulation Scenarios 5
a.
Correlation
between
the tag and
causal
SNPs, r Call Rate (=1-Missing Data Rate)
Sample 0.80 0.90 0.95 0.98 0.99 1.00
size
b Naı ¨ve
c Re-ranked
d Naı ¨ve Re-ranked Naı ¨ve Re-ranked Naı ¨ve Re-ranked Naı ¨ve Re-ranked Naı ¨ve Re-ranked
0.95 2500 0.17 0.20 0.26 0.25 0.25 0.25 0.30 0.30 0.33 0.33 0.45 0.45
5000 0.21 0.29 0.30 0.32 0.36 0.40 0.39 0.41 0.50 0.51 0.51 0.51
7500 0.18 0.34 0.33 0.43 0.46 0.50 0.53 0.55 0.61 0.60 0.71 0.71
10000 0.18 0.38 0.37 0.42 0.48 0.53 0.58 0.60 0.66 0.67 0.77 0.77
aSee Table 2 for details of the simulation models.
bequal number of cases and controls.
cNaı ¨ve is standard ranking without correction for selection or genotyping error.
dRe-ranked is ranking by corrected statistic in Equation 1.
doi:10.1371/journal.pgen.1003609.t004
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Overall, we observed that the tagging and genotyping accuracy
effects are non-trivial sources of bias that could obscure association
evidence at the causal SNP. The proposed re-ranking procedure is
simple to implement and can substantially increase the probability
of identifying the causal SNP. For low-coverage sequencing, we
recommend the re-ranking method to improve causal SNP
identification. For imputation and high-coverage sequencing, we
recommend that unfiltered SNPs in associated regions be
Figure 4. Naı ¨ve test statistics and re-ranking statistics for regions surrounding rs78246868 in the 8q24.21 region for association
with prostate cancer risk. Naı ¨ve test statistics (A), and re-ranking statistics adjusting for genotyping accuracy (B) for SNPs in LD (r
2.0.2) with
rs78246868. Circles highlight SNPs whose rank changed considerably after re-ranking. Color indicates pair-wise correlation with the most significant
SNP in the region selected based on the naı ¨ve ranking (purple diamond). Other shapes indicate genotyping accuracy over all 7 studies as measured
by rmeta. rs78246868 is no longer the most significant SNP in the region after re-ranking.
doi:10.1371/journal.pgen.1003609.g004
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recommend adjustment with the re-ranking method. Large
changes in rank should be carefully examined for underlying
issues such as heterogeneity among meta-analysis studies or
differential accuracy between cases and controls, and procedures
to correct for these issues should be incorporated.
Re-ranking is most beneficial when genotyping accuracy is
moderate to low, that is, the average correlation between the
Figure 5. Naı ¨ve test statistics and re-ranking statistics for regions surrounding rs8071558 in the 17q24.3 region for association with
prostate cancer risk. Naı ¨ve test statistics (A), and re-ranking statistics adjusting for genotyping accuracy (B) for SNPs in LD (r
2.0.2) with rs8071558.
Circles highlight SNPs whose rank changed considerably after re-ranking. Color indicates pair-wise correlation with the most significant SNP in the
region selected based on the naı ¨ve ranking (purple diamond). Other shape indicates genotyping accuracy over all 7 studies as measured by rmeta,
rs8071558 is no longer the most significant SNP in the region after re-ranking.
doi:10.1371/journal.pgen.1003609.g005
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imputed) SNPs is less than 0.97. A large number of post-GWAS
SNPs in a study may appear to be significant, but when not all
were directly genotyped with high accuracy, re-ranking can help
select the most probable causal SNPs for follow-up. High density
genotyping followed by low-coverage sequencing in the same
sample can produce misleading results, as demonstrated by our
simulations, so we do not recommend this design for identifying
causal variants. Our re-ranking method tends to down-rank the
tag SNP. If the tag SNP is suspected to be causal (e.g. based on
prior study), we recommend examining the rank of the tag SNP
using both the naı ¨ve and re-ranked methods when selecting SNPs
for further study. Several imputation and sequencing software
packages provide accurate estimates of r or quantities from which
r can be computed [24,39]. Re-ranking depends on accurate
estimates of r. Recalibration of sequencing quality scores can
greatly improve accuracy and so we recommend this step prior to
re-ranking [27].
Re-ranking is especially important when study-specific factors
exacerbate the effects of GWAS-based selection and genotyping
error. Such factors include: high genetic diversity which makes
sequencing reads difficult to align [27]; low LD among SNPs or
lack of population-specific reference panels which makes some
populations particularly difficult to impute (e.g. some African
populations [50]); and imputation error which can be as high as
10% for these populations. Low MAF SNPs tend to suffer from
both low power (which exacerbates the tagging effect) and high
genotyping error. Re-ranking can be applied to rare and low MAF
SNPs with allele counts large enough for test statistics to reach
asymptotic normality. Very low (16226) and extremely low
(0.1620.56) read depth sequencing has received recent attention
as a way to maximize cost efficiency and make use of off-target
sequencing data [29,32]. Error rates for such regions would be
both very high and highly variable among SNPs and so re-ranking
to account for errors in the estimated genotypes would be crucial.
When genotyping accuracy is extremely poor, the re-ranking
method may not be able to sufficiently improve the localization
success rate to ensure useful results. We recommend that
investigators consider the accuracy thresholds recommended by
the genotype calling or imputation algorithm they are using before
re-ranking is applied.
We emphasize that re-ranking improves the localization success
rate when applied to SNPs under the alternative, i.e. SNPs that are
themselves causal or in LD with a causal SNP. Including null
SNPs in the re-ranking procedure increases the number of SNPs
the causal must out-compete, and so we recommend that only
SNPs suspected to be under the alternative be included. In our
application we included all SNPs that had squared pairwise
correlation (r
2) with the index SNP (most significant SNP in the
region) greater than 0.2.
Existing methods that incorporate genotype uncertainty into
tests for association to reduce power lost due to genotyping error
or missing data [e.g. 51–54] do not completely recover lost
power, and so the genotyping accuracy effect will remain. The
simplest way to deal with genotype uncertainty in a test is to use
the expected additive genotype (i.e. the posterior mean or dosage)
in the standard linear or logistic regression. In this case, the re-
ranking method can be applied using the allele dosages in place of
called genotypes as described above. Guan and Stephens [55]
compared several frequentist and Bayesian methods that incor-
porate genotype uncertainty into tests for association. The re-
ranking procedure could be extended to any case where the
correlation between test statistics or Bayes factors can be worked
out.
We expect that re-ranking will play an important role as
sequencing costs fall and GWAS platform coverage increases.
Ultra-high density GWAS platforms are more likely to include tag
SNPs in very high correlation with the causal SNP, which
increases power to detect indirect association at the tag SNP.
However, without re-ranking, strong tagging also decreases power
to correctly identify the causal SNP in subsequent low-coverage
sequencing. Advances in GWAS and sequencing platforms will
allow researchers to drill down into lower MAFs and smaller effect
sizes. Both low MAF and small effect size yield lower power, which
exacerbates upward bias at the tag [20] and, therefore, the adverse
tagging effect. Low MAF SNPs tend to suffer from higher error
rates, which exacerbates the genotyping accuracy effect. Associ-
ation study sample sizes will therefore need to continue to increase,
so even as sequencing costs fall, it is anticipated that low-coverage
will continue to be the most cost-effective design for many studies,
despite the high genotyping error rates [27]. In conclusion, we
anticipate that re-ranking to correct for the adverse effects of
selection, tagging and differential genotyping accuracy rates
among SNPs will continue to be important in candidate causal
SNP identification for some time.
Supporting Information
Figure S1 Distribution of SNP-specific read depth using the
1000 Genomes low-coverage pilot data on 351,456 SNPs from
chromosome 1 in the CHB and JPT samples (October 2010
release; www.1000genomes.org/data).
(JPG)
Figure S2 Tagging effect decreases localization success rates
with or without the selection effect, rare SNP. The expected values
of the association test statistics at a tag SNP (red) and the causal
SNP (black), shading from 25
th–75
th percentiles (A,C), and the
localization success rates (B, D) for association studies (1000 cases
and 1000 controls) of one causal SNP (MAF=0.02; OR=1.5;
perfect genotyping accuracy) and one tag SNP (MAF=0.02; in
varying degree of correlation with the causal SNP, r=0.2 to 1;
perfect genotyping accuracy) with no selection for significance at
the tag SNP (A, B) or selection at the tag SNP requiring the test
statistic TG to be significant with p-value,0.05 (C, D).
(TIFF)
Figure S3 Tagging effect decreases localization success rates
with or without the selection effect, high frequency SNP. The
expected values of the association test statistics at a tag SNP (red)
and the causal SNP (black), shading from 25
th–75
th percentiles
(A,C), and the localization success rates (B, D) for association
studies (1000 cases and 1000 controls) of one causal SNP
(MAF=0.25; OR=1.25; perfect genotyping accuracy) and one
tag SNP (MAF=0.25; in varying degree of correlation with the
causal SNP, r=0.2 to 1; perfect genotyping accuracy) with no
selection for significance at the tag SNP (A, B) or selection at the
tag SNP requiring the test statistic TG to be significant with p-
value,0.05 (C, D).
(TIF)
Figure S4 Genotyping accuracy effect further reduces localiza-
tion success rates with or without the selection effect, rare SNP.
Localization success rates for association studies (1000 cases and
1000 controls) of one causal SNP (MAF=0.02; OR=1.5;
imperfect genotyping accuracy due to genotyping, sequenc-
ing or imputation errors resulting in correlation between the actual
and estimated genotypes rC=0.80 (blue dash-dotted) to 1
(black solid)) and one tag SNP (MAF=0.02; in varying degree
of correlation with the causal SNP, rCG=0.2 to 1 (horizontal axis);
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significance at the tag SNP (A) or selection at the tag SNP
requiring the test statistic TG to be significant with p-value,0.05
(B).
(TIFF)
Figure S5 Genotyping accuracy effect further reduces localiza-
tion success rates with or without the selection effect, high
frequency SNP. Localization success rates for association studies
(1000 cases and 1000 controls) of one causal SNP (MAF=0.25;
OR=1.25; imperfect genotyping accuracy due to genotyp-
ing, sequencing or imputation errors resulting in correlation
between the actual and estimated genotypes rC=0.80 (blue
dash-dotted) to 1 (black solid)) and one tag SNP
(MAF=0.25; in varying degree of correlation with the causal
SNP, rCG=0.2 to 1 (horizontal axis); perfect genotyping accuracy
with rG=1) with no selection for significance at the tag SNP (A)o r
selection at the tag SNP requiring the test statistic TG to be
significant with p-value,0.05 (B).
(TIFF)
Figure S6 Figure well-tagged causal SNPs sequenced with low
accuracy are unlikely to be correctly identified even as sample size
increases, rare SNP. Localization success rates for association
studies (50:50 cases:controls to 5000:5000 cases:controls, horizon-
tal axis) of one causal SNP (MAF=0.02; OR=1.5; imperfect
genotyping accuracy due to genotyping, sequencing or
imputation errors resulting in correlation between the actual and
estimated genotypes rC=0.95) and one tag SNP (MAF=0.02; in
high correlation with the causal SNP, rCG=0.8 (purple
solid) to 0.98 (red dashed); 100% genotyping accuracy with
rG=1) with no selection for significance at the tag SNP.
(TIFF)
Figure S7 Figure well-tagged causal SNPs sequenced with low
accuracy are unlikely to be correctly identified even as sample size
increases, high frequency SNP. Localization success rates for
association studies (50:50 cases:controls to 5000:5000 cases:con-
trols, horizontal axis) of one causal SNP (MAF=0.25; OR=1.25;
imperfect genotyping accuracy due to genotyping, sequenc-
ing or imputation errors resulting in correlation between the actual
and estimated genotypes rC=0.95) and one tag SNP
(MAF=0.25; in high correlation with the causal SNP,
rCG=0.8 (purple solid) to 0.98 (red dashed); 100%
genotyping accuracy with rG=1) with no selection for significance
at the tag SNP.
(TIFF)
Figure S8 Tagging effect decreases localization success rates
with or without the selection effect, 3 SNPs: 1 tag, 1 causal, 1 non-
causal sequencing SNP. The expected values of the association test
statistics at a tag SNP (red), the causal SNP (black), a non-causal
sequencing SNP (green), shading from 25
th–75
th percentiles (A,C),
and the localization success rates (B, D) for association studies
(1000 cases and 1000 controls) of one causal SNP (MAF=0.02;
correlation between causal and non-causal sequencing
SNPs=0.90, OR=1.5; perfect genotyping accuracy) and one
tag SNP (MAF=0.02; in varying degree of correlation with the
causal SNP, r=0.2 to 1; perfect genotyping accuracy) with no
selection for significance at the tag SNP (A, B) or selection at the
tag SNP requiring the test statistic TG to be significant with p-
value,0.05 (C, D).
(TIFF)
Figure S9 Tagging effect decreases localization success rates with
or without the selection effect 5 SNPs: 1 tag, 1 causal, 3 non-causal
sequencing SNPs. The expected values of the association test
statistics at a tag SNP (red), the causal SNP (black) and the
maximum test statistic of the 3 non-causal sequencing SNPs (green),
shading from 25
th–75
th percentiles (A,C), and the localization
success rates (B, D) for association studies (1000 cases and 1000
controls) of one causal SNP (MAF=0.02; OR=1.5; perfect
genotyping accuracy) and one tag SNP (MAF=0.02; correlation
between causal and non-causal sequencing SNPs=0.90, in varying
degree of correlation with the causal SNP, r=0.2 to 1; perfect
genotyping accuracy) with no selection for significance at the tag
SNP (A, B) or selection at the tag SNP requiring the test statistic TG
to be significant with p-value,0.05 (C, D).
(TIFF)
Figure S10 Tagging effect decreases localization success rates
with or without the selection effect 7 SNPs: 1 tag, 1 causal, 5 non-
causal sequencing SNPs. The expected values of the association test
statistics at a tag SNP (red), the causal SNP (black) and the
maximum test statistic of the 3 non-causal sequencing SNPs (green),
shading from 25
th–75
th percentiles (A,C), and the localization
success rates (B, D) for association studies (1000 cases and 1000
controls) of one causal SNP (MAF=0.02; OR=1.5; perfect
genotyping accuracy) and one tag SNP (MAF=0.02; correlation
between causal and non-causal sequencing SNPs=0.90, in varying
degree of correlation with the causal SNP, r=0.2 to 1; perfect
genotyping accuracy) with no selection for significance at the tag
SNP (A, B) or selection at the tag SNP requiring the test statistic TG
to be significant with p-value,0.05 (C, D).
(TIFF)
Figure S11 Naı ¨ve test statistics and re-ranking statistics for
regions surrounding rs1016343 on 8q24.21 and rs34255287 on
11q13.3 for association with prostate cancer risk. Naı ¨ve test
statistics (A, B), and re-ranking statistics adjusting for genotyping
accuracy (C, D) for SNPs in LD (r
2.0.2) with rs1016343 (A, C)o r
rs34255287 (B, D). Circles highlight SNPs whose rank changed
considerably after re-ranking. Color indicates pair-wise correlation
with the most significant SNP in the region. Shape indicates
genotyping accuracy over all 7 cohorts as measured by rMETA,
diamond is index SNP (most significant SNP from naive meta-
analysis).
(JPG)
Figure S12 Naı ¨ve test statistics and re-ranking statistics for
regions surrounding rs7816007 and rs6983267 on 8q24.21 for
association with prostate cancer risk. Naı ¨ve test statistics (A, B),
and re-ranking statistics adjusting for genotyping accuracy (C, D)
for SNPs in LD (r
2.0.2) with rs7816007 (A, C) or rs6983267 (B,
D). Color indicates pair-wise correlation with the most significant
SNP in the region. Shape indicates genotyping accuracy over all 7
cohorts as measured by rMETA, diamond is index SNP (most
significant SNP from naive meta-analysis).
(JPG)
Figure S13 Naı ¨ve test statistics and re-ranking statistics for
regions surrounding rs382434 on 8q24.21 for association with
prostate cancer risk. Naı ¨ve test statistics (A), and re-ranking statistics
adjusting for genotyping accuracy (B) for SNPs in LD (r
2.0.2) with
rs382434. Circles highlight SNPs whose rank changed considerably
after re-ranking. Color indicates pair-wise correlation with the most
significant SNP in the region. Shape indicates genotyping accuracy
over all 7 cohorts as measured by rMETA, diamond is index SNP
(most significant SNP from naive meta-analysis).
(JPG)
Table S1 Trends in power and localization success rate due to
tagging and genotyping accuracy effect.
(PDF)
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e for simulation
Scenarios 2, 3, 4.
(PDF)
Text S1 Ranking SNPs to identify candidate causal SNPs.
(PDF)
Text S2 Derivation of distribution of GWAS and tag SNP test
statistics.
(PDF)
Text S3 Low power exacerbates the selection effect.
(PDF)
Text S4 Tagging and coverage of GWAS platforms.
(PDF)
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